Blockchain's Evolving Role In The Life Sciences Supply Chain

By Arun Ghosh

In the Harvey Nash-KPMG 2018 survey of pharma CIOs, artificial intelligence was the leading technology, with 28 percent saying they made moderate to significant investments in the technology. Blockchain was tied with augmented/virtual reality, with 6 percent of CIOs saying it received a moderate/significant investment.

While blockchain has generated buzz from the volatility of cryptocurrencies as investments, the CIOs may be overlooking the technology’s potential to transform how pharmaceutical companies operate.